
Patricia L. Morris
Examiner (ID: 11378)
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1612, 1203, 1201, 1209, 1625 |
| Total Applications | 3798 |
| Issued Applications | 2697 |
| Pending Applications | 142 |
| Abandoned Applications | 965 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7216877
[patent_doc_number] => 20050054677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Process for preparing amine-substituted benzofurans'
[patent_app_type] => utility
[patent_app_number] => 10/946192
[patent_app_country] => US
[patent_app_date] => 2004-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11150
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054677.pdf
[firstpage_image] =>[orig_patent_app_number] => 10946192
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/946192 | Process for preparing amine-substituted benzofurans | Sep 20, 2004 | Abandoned |
Array
(
[id] => 6913023
[patent_doc_number] => 20050176781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Process for the preparation of [S(-) amlodipine - L (+)- hemitartarate'
[patent_app_type] => utility
[patent_app_number] => 10/937564
[patent_app_country] => US
[patent_app_date] => 2004-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1185
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20050176781.pdf
[firstpage_image] =>[orig_patent_app_number] => 10937564
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/937564 | Process for the preparation of S(−) amlodipine-L(+)-hemi taratarte | Sep 9, 2004 | Issued |
Array
(
[id] => 7208881
[patent_doc_number] => 20050043539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Process for the preparation of 5-[4-[2-[N-methyl-N-(2-pyridyl) amino] ethoxy] phenyl methyl] thiazolidine-2, 4-dione maleate'
[patent_app_type] => utility
[patent_app_number] => 10/938317
[patent_app_country] => US
[patent_app_date] => 2004-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2615
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20050043539.pdf
[firstpage_image] =>[orig_patent_app_number] => 10938317
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/938317 | Process for the preparation of 5-[4-[2-[N-methyl-N-(2-pyridyl) amino] ethoxy] phenyl methyl] thiazolidine-2, 4-dione maleate | Sep 9, 2004 | Abandoned |
Array
(
[id] => 7238478
[patent_doc_number] => 20050080114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-14
[patent_title] => 'Polymorph of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt'
[patent_app_type] => utility
[patent_app_number] => 10/935939
[patent_app_country] => US
[patent_app_date] => 2004-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2890
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0080/20050080114.pdf
[firstpage_image] =>[orig_patent_app_number] => 10935939
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/935939 | Polymorph of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt | Sep 7, 2004 | Abandoned |
Array
(
[id] => 7034554
[patent_doc_number] => 20050033064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Intermediates for the production of quinolone carboxylic acid derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/935357
[patent_app_country] => US
[patent_app_date] => 2004-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1951
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20050033064.pdf
[firstpage_image] =>[orig_patent_app_number] => 10935357
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/935357 | Intermediates for the production of quinolone carboxylic acid derivatives | Sep 7, 2004 | Abandoned |
Array
(
[id] => 560778
[patent_doc_number] => 07470790
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-30
[patent_title] => 'Heteroaromatic selective inhibitors of neuronal nitric oxide synthase'
[patent_app_type] => utility
[patent_app_number] => 10/935911
[patent_app_country] => US
[patent_app_date] => 2004-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 10071
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/470/07470790.pdf
[firstpage_image] =>[orig_patent_app_number] => 10935911
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/935911 | Heteroaromatic selective inhibitors of neuronal nitric oxide synthase | Sep 7, 2004 | Issued |
Array
(
[id] => 6972365
[patent_doc_number] => 20050038075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Intermediates for N-substituted carbamoyloxyalkyl-azolium derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/934551
[patent_app_country] => US
[patent_app_date] => 2004-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21554
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20050038075.pdf
[firstpage_image] =>[orig_patent_app_number] => 10934551
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/934551 | Intermediates for N-substituted carbamoyloxyalkyl-azolium derivatives | Sep 2, 2004 | Issued |
Array
(
[id] => 741674
[patent_doc_number] => 07030140
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-18
[patent_title] => 'Substituted benzimidazole antiviral agents'
[patent_app_type] => utility
[patent_app_number] => 10/934921
[patent_app_country] => US
[patent_app_date] => 2004-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13952
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/030/07030140.pdf
[firstpage_image] =>[orig_patent_app_number] => 10934921
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/934921 | Substituted benzimidazole antiviral agents | Sep 2, 2004 | Issued |
Array
(
[id] => 520631
[patent_doc_number] => 07189858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-13
[patent_title] => 'N-phenyl substituted carbamoyloxyalkyl-azolium derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/933577
[patent_app_country] => US
[patent_app_date] => 2004-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21555
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/189/07189858.pdf
[firstpage_image] =>[orig_patent_app_number] => 10933577
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/933577 | N-phenyl substituted carbamoyloxyalkyl-azolium derivatives | Sep 2, 2004 | Issued |
| 10/933820 | METHOD OF PRODUCING HIGH DENSITY TOCOPHEROL ACID SUCCINATE | Sep 2, 2004 | Abandoned |
Array
(
[id] => 5242972
[patent_doc_number] => 20070021467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Salts of omeprazole and esomeprazole II'
[patent_app_type] => utility
[patent_app_number] => 10/569820
[patent_app_country] => US
[patent_app_date] => 2004-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2823
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20070021467.pdf
[firstpage_image] =>[orig_patent_app_number] => 10569820
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/569820 | Salts of omeprazole and esomeprazole II | Aug 31, 2004 | Issued |
Array
(
[id] => 5142562
[patent_doc_number] => 20070004778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'New salts of omeprazole and esomeprazole i'
[patent_app_type] => utility
[patent_app_number] => 10/569819
[patent_app_country] => US
[patent_app_date] => 2004-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3609
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20070004778.pdf
[firstpage_image] =>[orig_patent_app_number] => 10569819
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/569819 | Salts of omeprazole and esomeprazole I | Aug 31, 2004 | Issued |
Array
(
[id] => 5136541
[patent_doc_number] => 20070078170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-05
[patent_title] => 'Process for the preparation of pioglitazone'
[patent_app_type] => utility
[patent_app_number] => 10/569999
[patent_app_country] => US
[patent_app_date] => 2004-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3126
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20070078170.pdf
[firstpage_image] =>[orig_patent_app_number] => 10569999
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/569999 | Process for the preparation of pioglitazone | Aug 29, 2004 | Abandoned |
Array
(
[id] => 7098571
[patent_doc_number] => 20050131030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Regioselective halogenation of nicotine and substituted nicotines'
[patent_app_type] => utility
[patent_app_number] => 10/926821
[patent_app_country] => US
[patent_app_date] => 2004-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5119
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20050131030.pdf
[firstpage_image] =>[orig_patent_app_number] => 10926821
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/926821 | Regioselective halogenation of nicotine and substituted nicotines | Aug 25, 2004 | Issued |
Array
(
[id] => 7216945
[patent_doc_number] => 20050054686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Imidazole derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/926670
[patent_app_country] => US
[patent_app_date] => 2004-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7129
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054686.pdf
[firstpage_image] =>[orig_patent_app_number] => 10926670
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/926670 | Imidazole derivatives | Aug 25, 2004 | Issued |
Array
(
[id] => 4760219
[patent_doc_number] => 20080312445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'Novel Crystalline Forms Of Nelfinavir Mesylate'
[patent_app_type] => utility
[patent_app_number] => 11/791557
[patent_app_country] => US
[patent_app_date] => 2004-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 1878
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20080312445.pdf
[firstpage_image] =>[orig_patent_app_number] => 11791557
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/791557 | Crystalline forms of Nelfinavir mesylate | Aug 22, 2004 | Issued |
Array
(
[id] => 5620095
[patent_doc_number] => 20060189629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'N-substituted benzimidazolyl c-Kit inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/921414
[patent_app_country] => US
[patent_app_date] => 2004-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22627
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20060189629.pdf
[firstpage_image] =>[orig_patent_app_number] => 10921414
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/921414 | N-substituted benzimidazolyl c-Kit inhibitors | Aug 15, 2004 | Issued |
Array
(
[id] => 6967207
[patent_doc_number] => 20050234104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => '3-[(2-{[4-(hexyloxycarbonylaminoiminomethyl)phenylamino]methyl}-1-methyl-1H-benzimidazol-5-carbonyl)pyridin-2-ylamino]propionic acid ethylester methansulfonate and its use as medicament'
[patent_app_type] => utility
[patent_app_number] => 10/918017
[patent_app_country] => US
[patent_app_date] => 2004-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3820
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20050234104.pdf
[firstpage_image] =>[orig_patent_app_number] => 10918017
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/918017 | 3-[(2-{[4-(hexyloxycarbonylaminoiminomethyl)phenylamino]methyl}-1-methyl-1H-benzimidazol-5-carbonyl)pyridin-2-ylamino]propionic acid ethylester methansulfonate and its use as medicament | Aug 12, 2004 | Abandoned |
Array
(
[id] => 5626134
[patent_doc_number] => 20060264639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Process'
[patent_app_type] => utility
[patent_app_number] => 10/569439
[patent_app_country] => US
[patent_app_date] => 2004-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5094
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20060264639.pdf
[firstpage_image] =>[orig_patent_app_number] => 10569439
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/569439 | Process | Aug 12, 2004 | Issued |
Array
(
[id] => 5609364
[patent_doc_number] => 20060270880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => '7-Azaindole derivatives as cox2 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/568399
[patent_app_country] => US
[patent_app_date] => 2004-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7364
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20060270880.pdf
[firstpage_image] =>[orig_patent_app_number] => 10568399
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/568399 | 7-Azaindole derivatives as cox2 inhibitors | Aug 10, 2004 | Abandoned |